Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

NIH seeks licensees for therapeutic/diagnostic HAV receptor

Feb. 24, 1997

Glaxo Wellcome discovers potent, selective CCK-B/gastrin antagonist

Feb. 20, 1997

Role of bFGF in gastric ulcer healing

Feb. 19, 1997

Another launch for SKB vaccine

Feb. 19, 1997

German introduction for hepatitis vaccine

Feb. 17, 1997

Potent dual CCK-A/CCK-B antagonist discovered by Japanese researchers

Feb. 11, 1997

Patent coverage granted for LXR antidiarrheal agent

Feb. 10, 1997

Isis updates activities related to ISIS-2302

Feb. 7, 1997

Lilly/Novo Nordisk discover candidate for IBS

Feb. 6, 1997

5-HT4 antagonists disclosed by Taisho

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.